| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3269742 | HPB | 2009 | 7 Pages |
Abstract
For patients presenting with stage T1b or greater IGC, the use of 18FDG PET-CT will help reduce the number of patients undergoing non-therapeutic re-exploration and may help to determine the likely prognosis. 18FDG PET-CT might be a useful tool for the selection of patients for potentially curative treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Jean M. Butte, Francisca Redondo, Enrique Waugh, Manuel Meneses, Rossana Pruzzo, Hugo Parada, Horacio Amaral, Hernán A. De La Fuente,